Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration‐QTc Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration‐QTc Analysis

Published:2022-09-13 Issue:1 Volume:12 Page:94-106
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharm in Drug Dev

Author:

Schneider Frank¹,Darpo Borje²,Loupe Pippa S.³,Xue Hongqi⁴,Knebel Helena⁵,Gutierrez Maria⁶,Gordon Mark Forrest³,Rabinovich‐Guilatt Laura⁵

Affiliation:

1. Teva Pharmaceutical Industries Ltd Berlin Germany

2. Clario Philadelphia Pennsylvania USA

3. Teva Pharmaceuticals West Chester Pennsylvania USA

4. Clario Pittsford New York USA

5. Teva Pharmaceutical Industries Ltd Netanya Israel

6. Teva Clinics Miramar Florida USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.1161

Reference28 articles.

1. Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial

2. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease

3. Randomized controlled trial of deutetrabenazine for tardive dyskinesia

4. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial

5. Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington’s disease: a review of clinical trial data

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease;Expert Review of Neurotherapeutics;2024-07-09

2. Concentration‐QTc Modeling of the DPP‐4 Inhibitor HSK7653 in a First‐in‐Human Study of Chinese Healthy Volunteers;Clinical Pharmacology in Drug Development;2024-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3